核素心肌灌注显像评价围产期心肌病的治疗效果
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Evaluating treatment effectiveness of peripartum cardiomyopathy by 99mTc-MIBI SPE MPI
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:利用核素心肌灌注显像观察围产期心肌病(perfusion of peripartum cardiomyopathy,PPCM)治疗前与治疗后左室形态大小及左室各壁心肌血流灌注的变化。方法:27例 PPCM患者,女性,年龄19~38岁。对其行控制心力衰竭及防止心室重构治疗,分别于治疗前、治疗后1月[(29.41±2.95) d]行静息心肌灌注显像;其中11例患者进行了6月[(6.31±0.84)月]随访复查。将左室分为17节段进行评分,采用半定量分析方法评价治疗前、后左室大小,放射性分布稀疏缺损范围及左室各节段评分的变化。结果:治疗后早期与治疗前心肌灌注显像相比,23例患者(85%)左心室缩小,放射性分布稀疏缺损范围缩小(P=0.001),心肌各节段(除前间壁基底段及后间壁基底段外)评分增加(Pmax=0.024);治疗后半年与治疗后早期比较,其中7例患者(64%)左心室大小恢复正常,放射性分布稀疏缺损范围进一步缩小(P=0.009),放射性分布稀疏缺损节段评分进一步增加(Pmax=0.048)。结论:99mTc-MIBI SPE MPI心肌灌注显像可用于评价PPCM的治疗效果。

    Abstract:

    Objective:To observe the morphology of left ventricle and changes in myocardial perfusion of peripartum cardiomyopathy (PPCM) before and after treatment by 99mTc-MIBI SPE MPI. Methods:Twenty-seven female patients with PPCM averaged 19-38 year-old were enrolled. Treatment preventing cardiac failure and ventricular remodeling were performed on them. 99mTc-MIBI SPE MPI was applied at one month((29.41±2.95) d) after the treatment. Eleven patients were followed-up for six months((6.31±0.84)months). Left ventricle was divided into 17 segments and semi quantitative assessment was performed to evaluate the morphology of left ventri-cle,perfusion defect range and changes in left ventricular segmental score before and after the treatment. Results:Left ventricular size was decreased in 23 patients(85%),perfusion defect range was decreased(P=0.001) and myocardial perfusion was increased in all left ventricular segments except basal segment of anterior wall and basal segment of posterior wall(Pmax=0.024) at early stage of treat-ment compared with those before treatment. Left ventricular size was normal in 7 patients(64%),perfusion defect range was further decreased in 11 patients(P=0.009) and myocardial perfusion was further increased(Pmax=0.048) after 6 months’ treatment compared with those before treatment. Conclusion:99mTc-MIBI SPE MPI can be used to assess treatment in patients with peripartum cardiomy-opathy.

    参考文献
    相似文献
    引证文献
引用本文

张 杰,闫新慧,高永举,武新宇,李晓飞.核素心肌灌注显像评价围产期心肌病的治疗效果[J].重庆医科大学学报,2013,(3):315-318

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2014-09-23
  • 出版日期:
文章二维码